HLA peptide therapy

HLA peptide therapy

  • CN 101,484,183 A
  • Filed: 05/09/2007
  • Published: 07/15/2009
  • Est. Priority Date: 05/09/2006
  • Status: Active Grant
First Claim
Patent Images

1. a peptide species or its derivant or analog, described polypeptide is made of from α

  • 3 domains of the main I of histocompatibility complex (MHC) class human leucocyte antigen (HLA) (HLA) and/or the continuous amino acid of membrane spaning domain 30 sources of less than.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×